{"id":"https://openalex.org/W4361945498","doi":"https://doi.org/10.1158/1078-0432.c.6523136","title":"Data from ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy","display_name":"Data from ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361945498","doi":"https://doi.org/10.1158/1078-0432.c.6523136"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6523136","doi":"https://doi.org/10.1158/1078-0432.c.6523136","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6523136","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6523136","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104273046","display_name":"Fan Lin","orcid":"https://orcid.org/0009-0003-2210-6279","observed_orcids":["https://orcid.org/0009-0003-2210-6279"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fan Lin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039593027","display_name":"Mark C. de Gooijer","orcid":"https://orcid.org/0000-0002-2812-991X","observed_orcids":["https://orcid.org/0000-0002-2812-991X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark C. de Gooijer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077619651","display_name":"Eloy Moreno Roig","orcid":"https://orcid.org/0000-0002-6457-6899","observed_orcids":["https://orcid.org/0000-0002-6457-6899"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eloy Moreno Roig","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073588166","display_name":"Levi C.M. Buil","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Levi C.M. Buil","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034949122","display_name":"Susan M. Christner","orcid":"https://orcid.org/0009-0005-9139-888X","observed_orcids":["https://orcid.org/0009-0005-9139-888X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan M. Christner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027371881","display_name":"Jan Hendrik Beumer","orcid":"https://orcid.org/0000-0002-8978-9401","observed_orcids":["https://orcid.org/0000-0002-8978-9401"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jan H. Beumer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103044043","display_name":"Thomas W\u00fcrdinger","orcid":"https://orcid.org/0000-0003-3696-738X","observed_orcids":["https://orcid.org/0000-0003-3696-738X","https://orcid.org/0000-0001-5648-433X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas W\u00fcrdinger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062227574","display_name":"Jos H. Beijnen","orcid":"https://orcid.org/0000-0003-0118-561X","observed_orcids":["https://orcid.org/0000-0003-0118-561X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jos H. Beijnen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5034151807","display_name":"Olaf van Tellingen","orcid":"https://orcid.org/0000-0002-1037-6269","observed_orcids":["https://orcid.org/0000-0002-1037-6269"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olaf van Tellingen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.8939999938011169,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.8939999938011169,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.07500000298023224,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.01679999940097332,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9620000123977661},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.9279999732971191},{"id":"https://openalex.org/keywords/veliparib","display_name":"veliparib","score":0.9900000095367432},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8889999985694885},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.925000011920929},{"id":"https://openalex.org/keywords/abcg2","display_name":"ABCG2","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pten","display_name":"PTEN","score":0.7889999747276306},{"id":"https://openalex.org/keywords/drug-efflux","display_name":"drug efflux","score":0.7360000014305115},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.9139999747276306},{"id":"https://openalex.org/keywords/elacridar","display_name":"elacridar","score":0.972000002861023},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.652999997138977},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8569999933242798},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.5249999761581421},{"id":"https://openalex.org/keywords/kras","display_name":"KRAS","score":0.7419999837875366},{"id":"https://openalex.org/keywords/allograft-model","display_name":"allograft model","score":0.6430000066757202},{"id":"https://openalex.org/keywords/spontaneous-tumor-model","display_name":"spontaneous tumor model","score":0.6309999823570251},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5669999718666077}],"concepts":[{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.8585361242294312},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.5091635584831238},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.475685715675354},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46139833331108093},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3981628119945526},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.37081995606422424}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.c.6523136","doi":"https://doi.org/10.1158/1078-0432.c.6523136","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6523136","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.c.6523136.v1","doi":"https://doi.org/10.1158/1078-0432.c.6523136.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6523136.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6523136","doi":"https://doi.org/10.1158/1078-0432.c.6523136","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6523136","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2108062634","https://openalex.org/W2063629211","https://openalex.org/W2337172610","https://openalex.org/W2123602693","https://openalex.org/W2109309448","https://openalex.org/W2288511411","https://openalex.org/W2017231073","https://openalex.org/W1912887175","https://openalex.org/W2335783268","https://openalex.org/W2889036193"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Little":[2],"is":[3,18,73,190],"known":[4],"about":[5],"the":[6,33,91,126,145,245],"optimal":[7],"clinical":[8,24,223],"use":[9],"of":[10,15,88,99,171,208,237,247],"ABT-888":[11,17,43,89,100,151,209,226],"(veliparib)":[12],"for":[13],"treatment":[14,135,143],"glioblastoma.":[16,46],"a":[19,96,193,232],"PARP":[20],"inhibitor":[21],"undergoing":[22],"extensive":[23],"evaluation":[25],"in":[26,45,79,114,129,144,156,165,175,179,210,216,250],"glioblastoma,":[27],"because":[28],"it":[29,189],"may":[30,243],"synergize":[31],"with":[32,184,192,218,225],"standard-of-care":[34],"temozolomide":[35],"(TMZ).":[36],"We":[37,49],"have":[38],"elucidated":[39],"important":[40],"factors":[41],"controlling":[42],"efficacy":[44,155,246],"Experimental":[47],"Design:":[48],"used":[50],"genetically":[51],"engineered":[52],"spontaneous":[53,146,162],"glioblastoma":[54,148,159,176,185,211,252],"mouse":[55],"models":[56,59],"and":[57,67,116,128,161,178,239],"allograft":[58],"that":[60,106,123,188],"were":[61],"orthotopically":[62],"transplanted":[63],"into":[64],"wild-type":[65,80,168],"(WT)":[66],"Abcb1/Abcg2-deficient":[68],"(KO)":[69],"recipients.":[70],"Results:":[71],"ABT-888/TMZ":[72],"not":[74],"efficacious":[75],"against":[76],"p53;p16Ink4a/p19Arf;K-Rasv12;LucR":[77,147],"allografts":[78,160],"recipients,":[81],"indicating":[82],"inherent":[83],"resistance.":[84],"Abcb1/Abcg2":[85,124,166],"mediated":[86],"efflux":[87],"at":[90,125],"blood\u2013brain":[92],"barrier":[93],"(BBB)":[94],"causes":[95],"5-fold":[97],"reduction":[98],"brain":[101],"penetration":[102],"(P":[103],"<":[104],"0.0001)":[105],"was":[107],"fully":[108],"reversible":[109],"by":[110],"elacridar.":[111],"Efficacy":[112],"studies":[113],"WT":[115],"KO":[117],"recipients":[118],"and/or":[119],"concomitant":[120],"elacridar":[121],"demonstrate":[122],"BBB":[127],"tumor":[130],"cells":[131],"impair":[132],"TMZ/ABT-888":[133,141,248],"combination":[134,142],"efficacy.":[136],"Elacridar":[137],"also":[138],"markedly":[139],"improved":[140],"model.":[149],"Importantly,":[150,235],"does":[152],"enhance":[153],"TMZ":[154],"Pten":[157],"deficient":[158],"tumors,":[163],"even":[164],"proficient":[167],"mice.":[169],"Loss":[170],"PTEN":[172,219],"occurs":[173],"frequently":[174],"(36%)":[177],"silico":[180],"analysis":[181],"on":[182],"patient":[183],"samples":[186],"revealed":[187],"associated":[191],"worse":[194],"overall":[195],"survival":[196],"(310":[197],"days":[198],"vs.":[199],"620":[200],"days,":[201],"n":[202],"=":[203],"117).":[204],"Conclusions:":[205],"The":[206],"potential":[207],"can":[212],"best":[213],"be":[214],"demonstrated":[215],"patients":[217,230],"null":[220],"tumors.":[221],"Therefore,":[222],"trials":[224],"should":[227],"evaluate":[228],"these":[229],"as":[231],"separate":[233],"group.":[234],"inhibition":[236],"ABCB1":[238],"ABCG2":[240],"(by":[241],"elacridar)":[242],"improve":[244],"therapy":[249],"all":[251],"patients.":[253],"Clin":[254],"Cancer":[255],"Res;":[256],"20(10);":[257],"2703\u201313.":[258],"\u00a92014":[259],"AACR.":[260]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2023-04-05T00:00:00"}